This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

The evolution of lung cancer treatment

Monday, July 29, 2013

Submitted by



Cancer Research UK announced a large investment into TRACERx, a project aimed at identifying genetic abnormalities in lung cancers and following their evolution over the lifetime of the patient.  Similar efforts are underway in France and the US.   

Add comment

Log in or register to post comments